Trial Outcomes & Findings for Venous Occlusion and Limb Swelling (NCT NCT02241343)

NCT ID: NCT02241343

Last Updated: 2020-11-24

Results Overview

Perometer measured leg volume from footplate to middle of knee joint (in standing position; ml)

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

1 participants

Primary outcome timeframe

30 minutes

Results posted on

2020-11-24

Participant Flow

Participant milestones

Participant milestones
Measure
Trial Cohort
All participants
Overall Study
STARTED
1
Overall Study
COMPLETED
0
Overall Study
NOT COMPLETED
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Trial Cohort
All participants
Overall Study
Adverse Event
1

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Trial Cohort
n=1 Participants
All participants
Age, Categorical
<=18 years
0 Participants
n=1 Participants
Age, Categorical
Between 18 and 65 years
1 Participants
n=1 Participants
Age, Categorical
>=65 years
0 Participants
n=1 Participants
Sex/Gender, Customized
Male
1 participants
n=1 Participants
Region of Enrollment
United Kingdom
1 participants
n=1 Participants

PRIMARY outcome

Timeframe: 30 minutes

Population: Adverse event precluded data collection

Perometer measured leg volume from footplate to middle of knee joint (in standing position; ml)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 30 minutes

Population: Zero analysed due to adverse event during protocol

Great saphenous vein diameter at the knee, taken with duplex ultrasound (cm)

Outcome measures

Outcome data not reported

Adverse Events

Trial Cohort

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Trial Cohort
n=1 participants at risk
Investigations
Faint
100.0%
1/1 • Number of events 1

Additional Information

Miss Kate Williams

Imperial College London

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place